New version of Seroquel OKd
From Times Wire Services
AstraZeneca said U.S. regulators had approved a new once-daily version of its Seroquel schizophrenia drug.
Seroquel is the London-based company’s second-biggest-selling drug, with global sales of $3.4 billion last year. Analysts said Food and Drug Administration approval of Seroquel XR was important to extend the life cycle of the family of drugs.
The new version of the drug is under patent until 2017.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
